Boosh to Introduce 2 New Frozen Boosh Bowls, One Refrigerated Heat n’ Eat Pouch In Q1
Vancouver, British Columbia--(Newsfile Corp. - December 29, 2021) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh"...
Year: 2021
iMEDISYNC UNVEILS WORLD’S FIRST INTEGRATED WIRELESS BRAIN EEG at CES 2022
SEOUL, South Korea, Dec. 29, 2021 /PRNewswire/ -- iMediSync, a leading AI-driven early detection and therapeutic platform for optimal brain...
ChemoMetec-aktien rykker til Large Cap
PRESSEMEDDELELSE 29. december 2021 ChemoMetec-aktien rykker til Large Cap Fra og med den 3. januar 2022 rykker ChemoMetec-aktien fra Mid...
Palisade Bio to Present at the H.C. Wainwright BIOCONNECT Virtual Conference and Biotech Showcase
CARLSBAD, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for...
ICU Medical, Inc. to Present at the J.P. Morgan 40th Annual Healthcare Conference
SAN CLEMENTE, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and...
Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
REDWOOD CITY, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive...
Salarius Pharmaceuticals Achieves Dosing Milestone in Ongoing Phase 1/2 Sarcoma Trial
Ewing sarcoma arm advances to second lead-in safety dosing cohort in Sarcoma trial evaluating seclidemstat in combination with chemotherapy agents...
Amedisys to Present at the 40th Annual J.P. Morgan Healthcare Conference
BATON ROUGE, La., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,...
Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese Medicine
Ji’an, Jiangxi, China, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and...
P3 Health Partners Announces Participation at the 40th Annual J.P. Morgan Healthcare Conference
HENDERSON, Nev., Dec. 29, 2021 (GLOBE NEWSWIRE) -- P3 Health Partners Inc. (NASDAQ: PIII, or “P3”), a patient-centered and physician-led...
Adaptive Biotechnologies to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
SEATTLE, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims...
Selecta Biosciences to Participate at the LifeSci Partners 11th Annual Corporate Access Event
WATERTOWN, Mass., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...
Statera Biopharma Submits Phase 3 Clinical Trial Protocol to FDA for Investigational Treatment of Pediatric Crohn’s Disease
Company developing STAT-201 as a novel therapy for immune modulation in treating pediatric patients with Crohn’s DiseaseFORT COLLINS, Colo., Dec....
Aptose to Participate in Two Biotech Events in January 2022
— H.C. Wainwright BIOCONNECT Virtual Conference — — 11th Annual LifeSci Partners Corporate Access Event — SAN DIEGO and TORONTO, Dec....
Aleafia Health Announces Closing of a New $19 Million Credit Facility and Extension of Existing Credit Facility
Credit Facility provides the Company with liquidity to fund operations and organic growth initiativesTwo-year term provides additional financial flexibilityTORONTO, Dec....
Philips completes cancellation of 33.5 million shares
December 29, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the...
SOPHiA GENETICS to Present at the 40th Annual J.P. Morgan Healthcare Conference
BOSTON and LAUSANNE, Switzerland, Dec. 29, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), announced today Chief Executive Officer...
Lucira Health and Co-Defend/Co-Protect Announce Expanded Partnership for 2022
Lucira is the only EUA authorized at-home self-test kit that delivers PCR-quality accuracy and early detectability in a single-use test...
Acarix carries out a directed issue of shares to guarantors in conjunction with completed rights issue
Press release Malmö, December 29, 2021 Acarix carries out a directed issue of shares to guarantors in conjunction with completed...
LIDDS announces positive topline results from the phase I dose-escalating study of NanoZolid®-formulated docetaxel
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that the systemic exposure of docetaxel after treating solid tumors with NanoZolid®-docetaxel...
